These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3880995)

  • 1. Comparison of acebutolol and propranolol in essential hypertension.
    Wahl J; Turlapaty P; Singh BN
    Am Heart J; 1985 Feb; 109(2):313-21. PubMed ID: 3880995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
    Davidov M
    Am Heart J; 1985 May; 109(5 Pt 2):1158-67. PubMed ID: 2859780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative hypotensive effects of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension: a double-blind multicenter evaluation.
    Wahl J; Singh BN; Thoden WR
    Am Heart J; 1986 Feb; 111(2):353-62. PubMed ID: 3511650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
    Abengowe CU
    J Int Med Res; 1985; 13(2):116-21. PubMed ID: 2860041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily acebutolol and atenolol in essential hypertension: double-blind crossover comparison.
    Turner AS; Brocklehurst JC; Napier RN
    Am Heart J; 1985 May; 109(5 Pt 2):1178-83. PubMed ID: 3993534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of oral acebutolol and propranolol at rest and during exercise in ischemic heart disease: double-blind placebo crossover study utilizing radionuclide ventriculography.
    Kaul S; Hecht HS; Seidman R; Hopkins J; Singh BN
    Am Heart J; 1984 Sep; 108(3 Pt 1):469-74. PubMed ID: 6382987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of age and race on clinical response to acebutolol in essential hypertension.
    Boyles PW
    Am Heart J; 1985 May; 109(5 Pt 2):1184-92. PubMed ID: 2859783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the acute effects of acebutolol and propranolol on blood pressure, heart rate and hormonal changes during graded treadmill exercise in patients with essential hypertension.
    Matsuura H; Masaoka S; Kanazawa I; Murano S; Tsuchioka Y; Kajiyama G
    Jpn J Med; 1989; 28(1):8-15. PubMed ID: 2657144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
    Chandraratna PA
    Am Heart J; 1985 May; 109(5 Pt 2):1198-204. PubMed ID: 3993535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac and pulmonary effects of acebutolol.
    Kumana CR; Kaye CM; Leighton M; Turner P; Hamer J
    Lancet; 1975 Jul; 2(7925):89-93. PubMed ID: 49736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of acebutolol in hypertension.
    Hansson L; Berglund G; Andersson O; Holm M
    Eur J Clin Pharmacol; 1977 Oct; 12(2):89-92. PubMed ID: 336378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
    Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly.
    Salvetti A; Lucchini M; Airoldi G; Cagianelli MA; Cinotti G; Cortese R; Diamanti G; Giuntoli F; Pedrinelli R; Pettinà G
    Eur J Clin Pharmacol; 1985; 29(3):275-9. PubMed ID: 3908126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of BAY l 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: comparison with standard dose nifedipine.
    Lejeune P; Gunselmann W; Hennies L; Hess K; Rittgerodt K; Winn K; Gfrerer G; Schreiber U
    Eur J Clin Pharmacol; 1985; 28(1):17-21. PubMed ID: 3886399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merits of adding a beta blocker (acebutolol) to a diuretic (hydrochlorothiazide) in the treatment of hypertension.
    Belleau LJ; Lebel M; Brossard JJ
    J Clin Pharmacol; 1982 Jan; 22(1):20-7. PubMed ID: 7037871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL; Levin DC; Manion CV
    Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.